Concomitant use of tamoxifen and endoxifen in postmenopausal early breast cancer: prediction of plasma levels by physiologically-based pharmacokinetic modeling

Dickschen, Kristin; Eissing, Thomas; Muerdter, Thomas; Schwab, Matthias; Willmann, Stefan; Hempel, Georg

dc.contributor.author	Schwab, Matthias
dc.date.accessioned	2016-05-25T15:52:11Z
dc.date.available	2016-05-25T15:52:11Z
dc.date.issued	2014
dc.identifier.issn	2193-1801
dc.identifier.uri	http://hdl.handle.net/10900/70113
dc.language.iso	en	en
dc.publisher	Springer International Publishing Ag	de_DE
dc.relation.uri	http://dx.doi.org/10.1186/2193-1801-3-285
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	500	de_DE
dc.title	Concomitant use of tamoxifen and endoxifen in postmenopausal early breast cancer: prediction of plasma levels by physiologically-based pharmacokinetic modeling	de_DE
dc.type	Article	de_DE
utue.quellen.id	20160330140844_02130
utue.personen.roh	Dickschen, Kristin
utue.personen.roh	Eissing, Thomas
utue.personen.roh	Muerdter, Thomas
utue.personen.roh	Schwab, Matthias
utue.personen.roh	Willmann, Stefan
utue.personen.roh	Hempel, Georg
dcterms.isPartOf.ZSTitelID	Springerplus	de_DE
dcterms.isPartOf.ZS-Issue	Article 285	de_DE
dcterms.isPartOf.ZS-Volume	3	de_DE
utue.fakultaet	04 Medizinische Fakultät